Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Impact of metabolic disorders on the structural, functional, and immunological integrity of the blood-brain barrier: Therapeutic avenues.

Journal article

Sheikh MH. et al, (2022), FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 36

A novel hCD68 CreERT(2) mouse strain for macrophage targeting in vivo

Conference paper

Rumianek A. et al, (2021), BRITISH JOURNAL OF PHARMACOLOGY, 178, 4949 - 4949

Novel anti-inflammatory activity of sunitinib malate identified in a macrophage drug-repurposing screen of FDA-approved medicines

Conference paper

Chaffey L. et al, (2021), BRITISH JOURNAL OF PHARMACOLOGY, 178, 4938 - 4939

X-LINKED IMMUNE DEFECT MICE ARE PROTECTED AGAINST SEPSIS-INDUCED CARDIAC DYSFUNCTION

Conference paper

O'Riordan C. et al, (2020), SHOCK, 53, 97 - 97

Role of annexin-A1 on blood-brain barrier functionality

Conference paper

Purvis GSD. et al, (2017), DIABETIC MEDICINE, 34, 64 - 64

I kappa B KINASE INHIBITOR ATTENUATES SEPSIS-INDUCED CARDIAC DYSFUNCTION IN MICE WITH CKD

Conference paper

Chen J. et al, (2016), SHOCK, 46, 29 - 30